|
|
|
Insider
Information: |
Spiegelman Daniel K |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
148,092 |
|
Indirect Shares
|
6,673 |
|
|
Direct
Value |
$5,100,357 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
154,765 |
|
|
Total
Value |
$5,100,357 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
CV Therapeutics Inc |
CVTX |
SVP, CFO |
2009-04-09 |
67,489 |
2009-04-09 |
6,673 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2009-12-04 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2019-04-30 |
47,686 |
2012-05-29 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Myriad Genetics Inc |
MYGN |
Director |
2024-06-04 |
32,917 |
2020-05-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
182 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2012-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
33,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-03-18 |
4 |
A |
$61.38 |
$860 |
D/D |
14 |
68,690 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-03-20 |
4 |
A |
$61.43 |
$556 |
D/D |
9 |
68,699 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-05-01 |
4 |
OE |
$39.06 |
$1,093,680 |
D/D |
28,000 |
61,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-05-01 |
4 |
S |
$64.42 |
$1,803,897 |
D/D |
(28,000) |
33,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,200 |
46,200 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-05-29 |
4 |
D |
$64.46 |
$269,701 |
D/D |
(4,184) |
42,016 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-06-19 |
4 |
A |
$58.57 |
$1,057 |
D/D |
18 |
68,717 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-07-01 |
4 |
AS |
$59.56 |
$243,063 |
D/D |
(4,066) |
37,950 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-09-04 |
4 |
AS |
$69.00 |
$621,000 |
D/D |
(9,000) |
37,950 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-09-04 |
4 |
OE |
$39.06 |
$351,540 |
D/D |
9,000 |
46,950 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-09-10 |
4 |
A |
$70.06 |
$1,053 |
D/D |
15 |
68,732 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-10-04 |
4 |
A |
$74.07 |
$370 |
D/D |
5 |
68,737 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-10-07 |
4 |
A |
$74.84 |
$449 |
D/D |
6 |
68,743 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-10-30 |
4 |
A |
$65.75 |
$595 |
D/D |
9 |
68,752 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-10-31 |
5 |
A |
$55.44 |
$4,047 |
D/D |
73 |
38,023 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-11-20 |
4 |
A |
$65.89 |
$527 |
D/D |
8 |
68,760 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-12-02 |
4 |
AS |
$70.14 |
$631,273 |
D/D |
(9,000) |
37,950 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-12-02 |
4 |
OE |
$39.06 |
$351,540 |
D/D |
9,000 |
46,950 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
64,273 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-03-03 |
4 |
AS |
$80.32 |
$642,530 |
D/D |
(8,000) |
64,273 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-03-03 |
4 |
OE |
$39.06 |
$312,480 |
D/D |
8,000 |
72,273 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-03-05 |
4 |
S |
$82.93 |
$995 |
D/D |
(12) |
68,748 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-04-30 |
4 |
A |
$49.50 |
$4,653 |
D/D |
94 |
64,367 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-05-02 |
4 |
S |
$58.02 |
$644 |
D/D |
(11) |
68,737 |
0 |
- |
|
182 Records found
|
|
Page 1 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|